HUTCHMED (China) HCM
NASDAQ HCM
$14.74 +0.56 (+3.95%)
At close: Oct 20, 2026 · 4:00 PM EDT

HUTCHMED (China) (HCM) EBITDA (2015 - 2019)

Updated

HUTCHMED (China)'s EBITDA was -$25.85 million in the year ended Dec 31, 2025, compared with -$31.36 million a year earlier.

Analysis

HUTCHMED (China) (HCM) EBITDA (2015 - 2019) Analysis & Trends

From the year ended Dec 31, 2014 onward, HUTCHMED (China) has reported EBITDA for 12 years.

  • Annual EBITDA has moved between -$399.03 million (the year ended Dec 31, 2022) and $26.58 million (the year ended Dec 31, 2023) over five years.
  • Per Business Quant data, EBITDA in earlier years was -$31.36 million in the year ended Dec 31, 2024, $26.58 million in the year ended Dec 31, 2023, -$399.03 million in the year ended Dec 31, 2022 and -$321.13 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.10 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 8.33 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -9.70 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 5.89 Bn
10 HUTCHMED (China) 2.53 Bn -2.41 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -37.13 Mn
Sep 30, 2019 -34.71 Mn
Dec 31, 2018 -23.14 Mn
Sep 30, 2018 -13.91 Mn
Jun 30, 2015 29.65 Mn
API Access

HUTCHMED (China) EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=HCM&period=max&api_key=YOUR_API_KEY